New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News For STML From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
April 27, 2015
10:00 EDTSTMLOn The Fly: Analyst Initiation Summary
Subscribe for More Information
07:07 EDTSTMLStemline initiated with a Buy at H.C. Wainwright
Subscribe for More Information
April 22, 2015
06:57 EDTSTMLStemline assumed with a Buy at Jefferies
Jefferies assumed Stemline Therapeutics with a Buy rating and lowered its price target for shares to $30 from $50. The firm believes Stemline's SL-401 could be approved and launched first in Blastic Plasmacytoid Dendritic Cell Neoplasm in 2017, and later in Acute Myeloid Leukemia in 2019.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use